Cogent Biosciences, Inc.
COGT
Rankning i aktier
#3336
Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted... Cogent Biosciences, Inc. is a biotechnology firm dedicated to creating targeted treatments for illnesses rooted in specific genetic anomalies. The company's primary therapeutic candidate is CGT9486, a selective tyrosine kinase inhibitor engineered to block the KIT D816V mutation, a key driver of systemic mastocytosis, along with other KIT exon 17 mutations observed in individuals suffering from advanced gastrointestinal stromal tumors (GIST). Furthermore, Cogent holds a licensing pact with Plexxikon Inc., granting it rights for the investigation, advancement, and marketing of bezuclastinib. Previously known as Unum Therapeutics Inc., the company adopted its current name, Cogent Biosciences, Inc., in October 2020. Established in 2014, Cogent Biosciences is headquartered in Cambridge, Massachusetts.
Aktiekurs
$30.11
Senast synkroniserad: 2026-10-19
Marknadsvärde
$5.22B
Förändring (1 dag)
2.00%
Förändring (1 år)
85.64%
Land
US
Handel Cogent Biosciences, Inc. (COGT)
Kategori
Healthcare
EPS för Cogent Biosciences, Inc. (COGT)
EPS per June 2026 TTM: $-2.31
Enligt Cogent Biosciences, Inc.s senaste finansiella rapporter och aktiekurs är bolagets nuvarande EPS (TTM) $-2.31. Vid slutet av 2023 hade bolaget ett EPS på $-2.42, en ökning jämfört med EPS från 2022 som var $-2.26.
EPS-historik för Cogent Biosciences, Inc. från 2015 till 2026
EPS vid slutet av varje år
| År | EPS | Ändra |
|---|---|---|
| 2026 (TTM) | $-2.31 | -6.10% |
| 2024 | $-2.46 | 1.65% |
| 2023 | $-2.42 | 7.08% |
| 2022 | $-2.26 | 22.16% |
| 2021 | $-1.85 | -69.17% |
| 2020 | $-6.00 | 51.13% |
| 2019 | $-3.97 | -28.47% |
| 2018 | $-5.55 | 60.87% |
| 2017 | $-3.45 | 11.29% |
| 2016 | $-3.10 | 174.34% |
| 2015 | $-1.13 | 0.00% |
EPS för liknande företag eller konkurrenter
| Företag | EPS | EPS-differens | Land |
|---|---|---|---|
| $17.32 | -849.78% |
US
|
|
| $-7.98 | 245.45% |
US
|
|
| $-5.29 | 129.00% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -1,300.87% |
NL
|
